We are live on ! Find out more
Boston Partners

Boston Partners Portfolio holdings

AUM $113B Turnover 18.52%
1-Year Est. Return 38.87%
This Fund
S&P 500
This Quarter Est. Return
-0.52%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$82.9B
AUM Growth
-$1.95B
Cap. Flow
-$950M
Cap. Flow %
-1.15%
Top 10 Hldgs %
17.78%
Holding
800
New
57
Increased
242
Reduced
371
Closed
71
Avg Time Held
2.5 years
Top 10 Avg Time Held
1.5 years
Top 20 Avg Time Held
1.8 years

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$704M
2
HWM icon
Howmet Aerospace
HWM
+$410M
3
NTR icon
Nutrien
NTR
+$410M
4
AXP icon
American Express
AXP
+$381M
5
STLA icon
Stellantis
STLA
+$351M

Sector Composition

Rank Sector Weight
1 Financials 29.69%
2 Technology 15.63%
3 Industrials 12.68%
4 Healthcare 11.72%
5 Energy 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
SLCA icon
776
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
– –
-64,539
Closed -$2.1M –
TRTN
777
DELISTED
Triton International Limited
TRTN
– –
-110,283
Closed -$4.13M –
IVC
778
DELISTED
Invacare Corporation
IVC
– –
-133,950
Closed -$2.26M –
AKS
779
DELISTED
AK Steel Holding Corp
AKS
– –
-703,934
Closed -$3.98M –
AREX
780
DELISTED
Approach Resources Inc.
AREX
– –
-501,260
Closed -$1.48M –
LEXEA
781
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
– –
-52,382
Closed -$2.32M –
LXFT
782
DELISTED
Luxoft Holding, Inc.
LXFT
– –
-78,676
Closed -$4.38M –
TVPT
783
DELISTED
Travelport Worldwide Limited
TVPT
– –
-125,871
Closed -$1.65M –
NXEO
784
DELISTED
Nexeo Solutions, Inc. Common Stock
NXEO
– –
-243,344
Closed -$2.21M –
AFSI
785
DELISTED
AmTrust Financial Services, Inc.
AFSI
– –
-1,241,624
Closed -$12.5M –
KLXI
786
DELISTED
KLX Inc.
KLXI
– –
-55,365
Closed -$3.19M –
RPXC
787
DELISTED
RPX Corporation
RPXC
– –
-2,121,334
Closed -$28.5M –
CSRA icon
788
DELISTED
CSRA Inc.
CSRA
– –
-816,656
Closed -$24.4M –
BBG
789
DELISTED
Bill Barrett Corp
BBG
– –
-2,687,483
Closed -$13.8M –
CASC
790
DELISTED
Cascadian Therapeutics, Inc.
CASC
– –
-380,143
Closed -$1.41M –
SRUNW
791
DELISTED
Silver Run Acquisition Corporation II
SRUNW
– –
-77,863
Closed -$115K –
SRUN
792
DELISTED
Silver Run Acquisition Corporation II Class A
SRUN
– –
-446,094
Closed -$4.42M –
POT
793
DELISTED
Potash Corp Of Saskatchewan
POT
– –
-154,355
Closed -$3.19M –
FMSA
794
DELISTED
Fairmount Santrol Holdings Inc.
FMSA
– –
-811,534
Closed -$4.24M –
ARC icon
795
DELISTED
ARC Document Solutions, Inc.
ARC
– –
-1,081,450
Closed -$2.76M –
CY
796
DELISTED
Cypress Semiconductor
CY
– –
-75,400
Closed -$1.15M –
CELG
797
DELISTED
Celgene Corp
CELG
– –
-150,174
Closed -$15.7M –
SHPG
798
DELISTED
Shire pic
SHPG
– –
-2,342,391
Closed -$363M –
DST
799
DELISTED
DST Systems Inc.
DST
– –
-62,433
Closed -$3.88M –
DO icon
800
DELISTED
Diamond Offshore Drilling
DO
– –
-142,429
Closed -$2.65M –

Similar funds

Boston Partners's Q1 2018 Portfolio in Review

As of Q1 2018, Boston Partners held 800 positions worth $82.9B, down 2.3% from $84.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Boston Partners's Q1 2018 filing shows 57 new, 242 increased, 371 reduced and 71 closed positions. Its largest new stake was Nutrien: 8,190,940 shares worth $387M. The largest sale was Apple, an estimated $674M.

By sector, the portfolio is most concentrated in Financials at 30% of assets, up from 29% a quarter earlier, followed by Technology and Industrials.

  • Boston Partners's largest Q1 2018 buy was Nutrien: 8,190,940 shares worth $387M.
  • Boston Partners added most to Johnson & Johnson in Q1 2018, an estimated $704M increase.
  • Boston Partners's biggest Q1 2018 reduction was Apple, cutting an estimated $674M.
  • Boston Partners fully exited Sanofi in Q1 2018, selling an estimated $364M.
  • Boston Partners's ten largest holdings make up 18% of its $82.9B portfolio in Q1 2018.
  • Boston Partners opened 57 new positions and closed 71 in Q1 2018.
  • Boston Partners's portfolio value fell 2.3% quarter-over-quarter to $82.9B.

Based on Boston Partners's 13F filing for Q1 2018, filed 4 May 2018.